About this Research Topic
This research topic aims to advance the development of biofilm inhibitors as a critical strategy to boost the effectiveness of existing antibacterial treatments, reduce the incidence of device-associated infections, and tackle the broader issue of multidrug-resistant infections. The goal is to catalyze the establishment and validation of novel therapeutic agents that can disrupt biofilm integrity and enhance pathogen susceptibility to drugs.
To deepen our understanding and refine therapeutic approaches, we aim at gathering further insights focusing on the following sub-themes:
o Natural products
o Synthetic and semi-synthetic drug candidates
o Essential oils
o Antibiofilm peptides
o Quorum quenching enzymes
o Nanoparticles
o Prebiotics, Probiotics, and Synbiotics
o Phage therapy
This research topic welcomes these article types: original research, review, mini-review and opinion.
Keywords: Antimicrobial resistance, Biofilm Inhibitors, ESKAPE Pathogens, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.